Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial

Peer Review reports

Original Submission
21 Dec 2020	Submitted	Original manuscript
31 Aug 2021	Reviewed	Reviewer Report - Muslim Syed
13 Sep 2021	Reviewed	Reviewer Report - Wenyao Wang
23 Sep 2021	Reviewed	Reviewer Report - Sohaib Ashraf
25 Oct 2021	Author responded	Author comments - Si-Yuan Lin
Resubmission - Version 2
25 Oct 2021	Submitted	Manuscript version 2
31 Oct 2021	Reviewed	Reviewer Report - Wenyao Wang
2 Nov 2021	Reviewed	Reviewer Report - Muslim Syed
2 Nov 2021	Reviewed	Reviewer Report - Sohaib Ashraf
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
8 Nov 2021	Editorially accepted
11 Dec 2021	Article published	10.1186/s13063-021-05807-3

Back to article page